SCHEMBL775291

SCHEMBL775291

CC[S+]([O-])c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
KCNN4 O15554 1/20 0.34
CES2 O00748 2/20 0.33
CES1 P23141 2/20 0.33
MIF P14174 1/20 0.33
PSIP1 O75475 1/20 0.32
NOS3 P29474 1/20 0.31
NOS2 P35228 1/20 0.31
LMNA P02545 2/20 0.31
TSHR P16473 1/20 0.30
ALOX12 P18054 1/20 0.30
ACHE P22303 1/20 0.30
ELANE P08246 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3388541 1.00 TP53 (0.38) TP53CYP3A4TDP1KCNN4CES2
SCHEMBL16363528 1.00 TP53 (0.38) TP53CYP3A4TDP1KCNN4CES2
SCHEMBL19199344 0.81 SLC6A4 (0.41) TP53KCNN4LMNA
SCHEMBL29182302 0.80 TP53 (0.40) TP53CYP3A4TDP1KCNN4CES2
SCHEMBL776216 0.80 TP53 (0.40) TP53CYP3A4TDP1KCNN4CES2
SCHEMBL30828031 0.80 TP53 (0.40) TP53CYP3A4TDP1KCNN4CES2
SCHEMBL1314975 0.78 CYP3A4 (0.38) CYP3A4TDP1CES2CES1
SCHEMBL20921242 0.78 CYP3A4 (0.38) CYP3A4TDP1CES2CES1
SCHEMBL6913189 0.78 CYP3A4 (0.38) CYP3A4TDP1CES2CES1
SCHEMBL12283711 0.77 ACHE (0.40) CYP3A4TDP1ACHEELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 375 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250391919-A1 ELECTROLYTE SOLUTION, BATTERY CELL, BATTERY, AND POWER CONSUMING APPARATUS CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) 2025-12-25 US claimed
EP-4664591-A1 ELECTROLYTE SOLUTION, BATTERY CELL, BATTERY, AND ELECTRIC DEVICE Contemporary Amperex Technology Co., Limited (CN) 2025-12-17 EP claimed
CN-120019522-A Electrolyte, battery cell, battery and electricity utilization device 宁德时代新能源科技股份有限公司 2025-05-16 CN claimed
US-20250110071-A1 USING HYPERPOLARISED 15N DERIVED SYNTHONS TO CREATE HYPERPHARMACEUTICALS THROUGH SABRE UNIVERSITY OF YORK (GB) 2025-04-03 US claimed
CN-119452496-A Electrolyte, battery and electricity utilization device 宁德时代新能源科技股份有限公司 2025-02-14 CN claimed
WO-2024212188-A1 ELECTROLYTE SOLUTION, BATTERY CELL, BATTERY, AND ELECTRIC DEVICE 宁德时代新能源科技股份有限公司 2024-10-17 WO claimed
WO-2024182918-A1 ELECTROLYTE, BATTERY AND ELECTRICAL APPARATUS 宁德时代新能源科技股份有限公司 2024-09-12 WO claimed
WO-2023144521-A1 USING HYPERPOLARISED 15N DERIVED SYNTHONS TO CREATE HYPERPHARMACEUTICALS THROUGH SABRE UNIVERSITY OF YORK (GB) 2023-08-03 WO claimed
CN-115582136-A Sulfoxide catalyst for desulfurization and denitrification and preparation method thereof 国能龙源环保有限公司 2023-01-10 CN claimed
EP-2481760-B1 INITIATOR SYSTEM FOR CATIONIC POLYMERIZATION AND POLYMERIZATION METHOD USING SAME CHINA PETROLEUM & CHEM CORP (CN) 2021-05-05 EP claimed
CN-102532368-A Rare earth catalyst and method for polymerizing conjugated diene by using same UNIV BEIJING CHEMICAL 2012-07-04 CN claimed
CN-101372676-B A strain of Rhodococcus and use thereof for preparing optical pure chiral sulphoxide UNIV EAST CHINA SCIENCE & TECH 2010-08-18 CN claimed
US-20100080843-A1 Natural and synthetic sulfur and selenium analogs and polymer conjugated forms thereof for the modulation of angiogenesis The Research Foundation of the State University Of New York at Albany (US) 2010-04-01 US claimed
WO-2007017900-A2 PREPARATION OF PARA DICHLOROBENZENE FROM BENZENE OR MONO CHLOROBENZENE MANDAL SISIR KUMAR (IN) 2007-02-15 WO claimed
WO-2007005670-A2 NATURAL AND SYNTHETIC SULFOXIDE, SELENONE AND SELENOXIDE ANALOGS AND POLYMER CONJUGATED FORMS THEREOF FOR THE MODULATION OF ANGIOGENESIS THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK (US) 2007-01-11 WO claimed
CN-1288222-C Phosphorescent light-emitting material LAIDE SCIENCE & TECHNOLOGY CO (CN) 2006-12-06 CN claimed
US-6838019-B2 Phosphorescent material and electroluminescent device using thereof RITEK CORPORATION (TW) 2005-01-04 US claimed
CN-1464027-A Phosphorescent light-emitting material LAIDE SCIENCE & TECHNOLOGY CO (CN) 2003-12-31 CN claimed
EP-1319004-A2 SUBSTITUTED AZEPINO[4,5-B]INDOLE DERIVATIVES PHARMACIA & UPJOHN COMPANY (US) 2003-06-18 EP claimed
WO-2002024701-A2 SUBSTITUTED AZEPINO[4,5B)INDOLE DERIVATIVES PHARMACIA & UPJOHN COMPANY (US) 2002-03-28 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250391919-A1 ELECTROLYTE SOLUTION, BATTERY CELL, BATTERY, AND POWER CONSUMING APPARATUS HCN1, NHERF1, HCN2 TP53 3380/4885CYP3A4 4554/4885TDP1 2181/4885
US-20100080843-A1 Natural and synthetic sulfur and selenium analogs and polymer conjugated forms thereof for the modulation of angiogenesis SCLY, SELE, GPX1 TP53 510/4885CYP3A4 3888/4885TDP1 3998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.